Medical weight loss.
Done right.

GLP-1 is a naturally occurring hormone that regulates appetite and blood sugar. GLP-1 medications mimic this hormone to help reduce hunger signals and support sustainable weight management. All prescriptions are reviewed by a licensed clinician based on your individual health history.

Food noise is the constant mental preoccupation with food — persistent thoughts about eating that feel difficult to control. It is driven by biology, not willpower. Many patients on GLP-1 therapy report a meaningful reduction in food noise, which supports healthier eating patterns over time.

GLP-1 microdosing uses lower doses of GLP-1 medications for metabolic optimization rather than aggressive weight loss. It may be appropriate for adults with a BMI above 20 who want to improve metabolic health or reduce food noise without pursuing significant weight reduction. Eligibility is determined by a licensed clinician.

You complete a clinical intake online. A licensed provider reviews your information and determines whether treatment is appropriate. If approved, your personalized protocol is coordinated through SEVEN and medication ships to your door. Ongoing clinical support is included.

Eligibility is determined by a licensed clinician based on your medical history, goals, and clinical criteria. GLP-1 therapy is not appropriate for everyone. SEVEN providers review each patient individually before any treatment is prescribed or dispensed.

Yes. All treatment decisions are made by licensed providers. No prescription is issued without a clinical review of your intake. SEVEN does not manufacture medications — all pharmacy fulfillment is handled by licensed pharmacy partners.

Lab requirements vary based on your health history and the program your provider recommends. Your provider will advise you on any labs needed during the intake review. Some programs may proceed without initial labs; others may require baseline bloodwork before treatment begins.

SEVEN is designed to serve patients across the United States. Program availability may vary by state. You will be notified of availability in your state when you join the waitlist.

SEVEN is clinician-founded, not investor-driven. Every treatment protocol is built around individual clinical evaluation — not a single medication pathway. Programs are developed by licensed providers based on your specific health history, goals, and clinical eligibility. SEVEN offers medical weight loss, metabolic health, sexual health, and longevity programs with ongoing clinical support throughout.

Yes. SEVEN offers clinician-guided erectile dysfunction treatment online using FDA-approved PDE5 inhibitors including sildenafil and tadalafil. No in-person visit required. All prescriptions require individual clinician review. Learn about ED treatment →

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy production, DNA repair, and longevity pathways. NAD+ levels decline with age. SEVEN offers clinician-guided NAD+ programs as part of our metabolic health and longevity platform. Learn about NAD+ therapy →

SEVEN is preparing to launch and currently accepting early access applications. Initial onboarding capacity will be limited. Waitlist members will be among the first notified when enrollment opens.